document.getElementById('FCDPublications').innerHTML='
Brunner HI, Cody EM, Devarajan P, Huang B, Chen C, Sinibaldi D, Ramaswamy M, Knagenhjelm J, Jones F, Brohawn PZ, Tummala R, Lindholm C, White WI. The Renal Activity Index for Lupus Identifies Active Renal Disease and Treatment Response in Adult Patients With Systemic Lupus Erythematosus and Lupus Nephritis. Arthritis Care Res (Hoboken). 2025 Oct 27 PMID: 41144892 10/27/2025
Cody EM, Sproles A, Rose J, Huang B, Devarajan P, Brunner HI, Thornton S. Development and Validation of Multiplex Assays for Lupus Nephritis Activity Biomarkers. Kidney Int Rep. 2025 Jul;10(7):2255-2264 PMID: 40677325 PMCID: PMC12266149 07/18/2025
Sagcal-Gironella ACP, Merritt A, Mizuno T, Dharnidharka VR, McDonald J, DeGuzman M, Wahezi D, Goilav B, Onel K, Kim S, Cody E, Wu EY, Cannon L, Hayward K, Okamura DM, Patel PN, Greenbaum LA, Rouster-Stevens KA, Cooper JC, Ruth NM, Ardoin S, Cook K, Borgia RE, Hersh A, Huang B, Devarajan P, Brunner H. Efficacy and Safety of Pharmacokinetically-Driven Dosing of Mycophenolate Mofetil for the Treatment of Pediatric Proliferative Lupus Nephritis-A Double-Blind Placebo Controlled Clinical Trial (The Pediatric Lupus Nephritis Mycophenolate Mofetil Study). J Clin Trials. 2024;14(4) PMID: 39035447 PMCID: PMC11258879 07/22/2024
Cody E, Brunner HI. Renal disease in pediatric rheumatology. Curr Opin Rheumatol. 2024 Sep 01;36(5):322-327 PMID: 38752864 PMCID: PMC12450297 SCOPUS ID: 2-s2.0-85200275490 05/16/2024
Cody EM, Wilson BE, Ogbu EA, Huggins JL, Chen C, Qiu T, Ting TV, Flores F, Huang B, Brunner HI. Usefulness of the lupus low disease activity state as a treatment target in childhood-onset SLE. Lupus Sci Med. 2023 May;10(1) PMID: 37253553 PMCID: PMC10230998 05/31/2023
Hingorani S, Gibson KL, Xie Y, Wang Y, Eddy S, Hartman J, Sampson M, Cassol C, Thomas D, Gipson DS, Trachtman H, Srivastava T, Reidy K, NEPTUNE Pediatric Working Group. The association of low birthweight and prematurity on outcomes in children and adults with nephrotic syndrome-a NEPTUNE cohort study. Pediatr Nephrol. 2023 Oct;38(10):3297-3308 PMID: 37140708 PMCID: PMC11186376 SCOPUS ID: 2-s2.0-85158005228 05/04/2023
Cody EM, Varnell C Jr, Lazear D, VandenHeuvel K, Flores FX, Woodle ES, Hooper DK. Carfilzomib-based antibody mediated rejection therapy in pediatric kidney transplant recipients. Pediatr Transplant. 2023 Nov;27(7):e14534 PMID: 37132092 SCOPUS ID: 2-s2.0-85158001703 05/03/2023
Cody EM, Wenderfer SE, Sullivan KE, Kim AHJ, Figg W, Ghumman H, Qiu T, Huang B, Devarajan P, Brunner HI. Urine biomarker score captures response to induction therapy with lupus nephritis. Pediatr Nephrol. 2023 Aug;38(8):2679-2688 PMID: 36715772 PMCID: PMC10393841 SCOPUS ID: 2-s2.0-85147041230 01/31/2023
Stotter BR, Cody E, Gu H, Daga A, Greenbaum LA, Duong MD, Mazo A, Goilav B, Boneparth A, Kallash M, Zeid A, Seeherunvong W, Scobell RR, Alhamoud I, Carter CE, Shah S, Straatmann CE, Dixon BP, Cooper JC, Nelson RD, Levy DM, Brunner HI, Verghese PS, Wenderfer SE. Acute kidney injury requiring kidney replacement therapy in childhood lupus nephritis: a cohort study of the Pediatric Nephrology Research Consortium and Childhood Arthritis and Rheumatology Research Alliance. Pediatr Nephrol. 2023 May;38(5):1653-1665 PMID: 36251074 PMCID: PMC12498489 SCOPUS ID: 2-s2.0-85139953316 10/18/2022
Cody EM, Rose JE, Huang B, Qiu T, Brunner HI, Devarajan P. Stability of novel urinary biomarkers used for lupus nephritis. Front Pediatr. 2022;10:974049 PMID: 35967565 PMCID: PMC9372620 08/16/2022